Strs Ohio Acquires 135,212 Shares of Agilent Technologies, Inc. $A

Strs Ohio raised its holdings in Agilent Technologies, Inc. (NYSE:A) by 1,984.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 142,026 shares of the medical research company’s stock after acquiring an additional 135,212 shares during the quarter. Strs Ohio’s holdings in Agilent Technologies were worth $19,325,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Bridgefront Capital LLC bought a new position in Agilent Technologies in the third quarter valued at approximately $1,323,000. Wellington Management Group LLP boosted its position in shares of Agilent Technologies by 4.8% during the third quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock worth $1,203,990,000 after purchasing an additional 433,342 shares in the last quarter. Envestnet Asset Management Inc. boosted its position in shares of Agilent Technologies by 3.8% during the third quarter. Envestnet Asset Management Inc. now owns 607,914 shares of the medical research company’s stock worth $78,026,000 after purchasing an additional 22,498 shares in the last quarter. First Horizon Corp bought a new position in shares of Agilent Technologies during the third quarter worth $1,378,000. Finally, Lmcg Investments LLC boosted its position in shares of Agilent Technologies by 13.6% during the third quarter. Lmcg Investments LLC now owns 82,905 shares of the medical research company’s stock worth $10,641,000 after purchasing an additional 9,911 shares in the last quarter.

Agilent Technologies Trading Up 0.0%

A opened at $114.57 on Monday. The stock has a market capitalization of $32.38 billion, a P/E ratio of 25.29, a P/E/G ratio of 2.41 and a beta of 1.22. Agilent Technologies, Inc. has a 12 month low of $104.36 and a 12 month high of $160.27. The firm’s fifty day simple moving average is $116.34 and its 200 day simple moving average is $132.45. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing the consensus estimate of $1.37 by ($0.01). The company had revenue of $1.80 billion during the quarter, compared to the consensus estimate of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The company’s revenue was up 7.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, research analysts anticipate that Agilent Technologies, Inc. will post 5.95 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, April 22nd. Investors of record on Tuesday, March 31st were given a $0.255 dividend. This represents a $1.02 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend was Tuesday, March 31st. Agilent Technologies’s payout ratio is currently 22.52%.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the stock. Barclays reduced their price target on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Morgan Stanley reduced their price target on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. Evercore raised shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and lifted their price target for the stock from $155.00 to $160.00 in a research report on Monday, January 5th. Wells Fargo & Company reduced their price target on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research report on Thursday, February 26th. Finally, TD Cowen reduced their price target on shares of Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Buy” and a consensus target price of $163.71.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.